[go: up one dir, main page]

EG20525A - Benzopyrans - Google Patents

Benzopyrans

Info

Publication number
EG20525A
EG20525A EG46794A EG46794A EG20525A EG 20525 A EG20525 A EG 20525A EG 46794 A EG46794 A EG 46794A EG 46794 A EG46794 A EG 46794A EG 20525 A EG20525 A EG 20525A
Authority
EG
Egypt
Prior art keywords
disease
compounds
motility
asthma
hypertension
Prior art date
Application number
EG46794A
Other languages
English (en)
Original Assignee
Pfizer Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Res & Dev filed Critical Pfizer Res & Dev
Application granted granted Critical
Publication of EG20525A publication Critical patent/EG20525A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/70Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EG46794A 1993-08-04 1994-08-03 Benzopyrans EG20525A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939316111A GB9316111D0 (en) 1993-08-04 1993-08-04 Benzopyrans

Publications (1)

Publication Number Publication Date
EG20525A true EG20525A (en) 1999-06-30

Family

ID=10739921

Family Applications (1)

Application Number Title Priority Date Filing Date
EG46794A EG20525A (en) 1993-08-04 1994-08-03 Benzopyrans

Country Status (28)

Country Link
US (2) US5912244A (es)
EP (1) EP0712398B1 (es)
JP (1) JP2871098B2 (es)
KR (1) KR0175532B1 (es)
CN (1) CN1128536A (es)
AT (1) ATE152716T1 (es)
AU (1) AU684817B2 (es)
CA (1) CA2168563C (es)
CO (1) CO4230234A1 (es)
CZ (1) CZ281853B6 (es)
DE (1) DE69403084T2 (es)
DK (1) DK0712398T3 (es)
EC (1) ECSP941140A (es)
EG (1) EG20525A (es)
ES (1) ES2102870T3 (es)
FI (1) FI960487L (es)
GB (1) GB9316111D0 (es)
GR (1) GR3023521T3 (es)
HU (1) HUT75120A (es)
IL (1) IL110488A (es)
NO (1) NO960441D0 (es)
NZ (1) NZ271344A (es)
PE (1) PE56894A1 (es)
PL (1) PL312788A1 (es)
SG (1) SG42817A1 (es)
TW (1) TW333532B (es)
WO (1) WO1995004730A1 (es)
ZA (1) ZA945774B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5573758A (en) * 1995-04-28 1996-11-12 Allergan Method for reducing intraocular pressure in the mammalian eye by administration of potassium channel blockers
US5869478A (en) * 1995-06-07 1999-02-09 Bristol-Myers Squibb Company Sulfonamido substituted benzopyran derivatives
CZ398598A3 (cs) * 1996-06-07 1999-07-14 The Procter & Gamble Company Dihydrobenzopyran, prostředek ho obsahující a způsob léčení zánětu nebo bolesti a artritidy
US6333352B1 (en) * 2000-04-05 2001-12-25 Mimicking Man Manually, Inc. Method of treating benign positional vertigo
MY149050A (en) * 2001-04-16 2013-07-15 Merck Sharp & Dohme 3,4 di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands
JP2005505586A (ja) * 2001-10-04 2005-02-24 ワイス 5−ヒドロキシトリプタミン−6リガンドとしてのクロマン誘導体
ATE407724T1 (de) * 2002-11-12 2008-09-15 Warner Lambert Co Methode zur stimulierung von haarwuchs auf der basis von benzopyranen
CA2555741C (en) * 2004-02-12 2010-03-23 Warner-Lambert Company Llc Method of stimulating hair growth
US20090110892A1 (en) * 2004-06-30 2009-04-30 General Electric Company System and method for making a graded barrier coating
US7655656B2 (en) * 2004-07-16 2010-02-02 Pfizer Inc. Hair growth promoting agents
BRPI0513401A (pt) * 2004-07-19 2008-05-06 Warner Lambert Co formulação para estimular crescimento de cabelo
CA2591810A1 (en) * 2004-12-21 2006-06-29 F.Hoffmann-La Roche Ag Chroman derivatives and uses thereof in the treatment of cns disorders

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3835011A1 (de) * 1988-10-14 1990-04-19 Merck Patent Gmbh Chromanderivate
EP0277611B1 (de) * 1987-02-04 1993-06-16 Hoechst Aktiengesellschaft Alkylsubstituierte N-Benzopyranyllactame, Verfahren zu ihrer Herstellung, ihre Verwendung sowie pharmazeutische Präparate auf Basis dieser Verbindungen
DE3703227A1 (de) * 1987-02-04 1988-08-18 Hoechst Ag Substituierte 3,4-dihydro-2h-benzopyrane, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen
DE3811017A1 (de) * 1988-03-31 1989-10-19 Hoechst Ag Ungesaettigte n-benzopyranyllactame
AU628331B2 (en) * 1988-05-06 1992-09-17 Merck Patent Gesellschaft Mit Beschrankter Haftung Chroman derivatives
EP0346724A1 (de) * 1988-06-16 1989-12-20 MERCK PATENT GmbH Chromanderivate
DE3824446A1 (de) * 1988-07-19 1990-01-25 Hoechst Ag, 6230 Frankfurt Verwendung substituierter 3,4-dihydro-2h-benzopyrane als heilmittel gegen obstruktive funktionsstoerungen der lunge und/oder stoerungen der ableitenden harnwege
DE3827532A1 (de) * 1988-08-13 1990-03-01 Hoechst Ag 6-aroyl-substituierte 3,4-dihydro-2h-benzopyrane, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen
DE3918041A1 (de) * 1989-06-02 1990-12-06 Merck Patent Gmbh Chromanderivate
US5061813A (en) * 1990-04-02 1991-10-29 E. R. Squibb & Sons, Inc. Substituted cyanoimino benzopyranes
GB2242628A (en) * 1990-04-06 1991-10-09 Sandoz Ltd Asthma prophylactic use of K+ channel activators
TW244350B (es) * 1991-12-14 1995-04-01 Hoechst Ag
JPH0673061A (ja) * 1992-01-18 1994-03-15 Hoechst Ag 6−置換クロメン類のエナンチオ選択的エポキシ化方法

Also Published As

Publication number Publication date
NO960441L (no) 1996-02-02
GB9316111D0 (en) 1993-09-22
HUT75120A (en) 1997-04-28
US6071938A (en) 2000-06-06
FI960487A0 (fi) 1996-02-02
PE56894A1 (es) 1995-02-07
AU7494894A (en) 1995-02-28
PL312788A1 (en) 1996-05-13
ECSP941140A (es) 1995-01-16
CZ281853B6 (cs) 1997-02-12
EP0712398B1 (en) 1997-05-07
SG42817A1 (en) 1997-10-17
FI960487L (fi) 1996-02-02
DE69403084D1 (de) 1997-06-12
NO960441D0 (no) 1996-02-02
KR0175532B1 (ko) 1999-02-18
ES2102870T3 (es) 1997-08-01
IL110488A (en) 1999-08-17
NZ271344A (en) 1997-10-24
CO4230234A1 (es) 1995-10-19
WO1995004730A1 (en) 1995-02-16
EP0712398A1 (en) 1996-05-22
AU684817B2 (en) 1998-01-08
US5912244A (en) 1999-06-15
CZ33196A3 (en) 1996-05-15
ATE152716T1 (de) 1997-05-15
DK0712398T3 (da) 1997-10-27
CN1128536A (zh) 1996-08-07
TW333532B (en) 1998-06-11
GR3023521T3 (en) 1997-08-29
DE69403084T2 (de) 1997-08-14
JP2871098B2 (ja) 1999-03-17
ZA945774B (en) 1996-02-05
IL110488A0 (en) 1994-10-21
JPH08508042A (ja) 1996-08-27
CA2168563C (en) 1999-09-07
CA2168563A1 (en) 1995-02-16

Similar Documents

Publication Publication Date Title
MX9705590A (es) Compuestos heterociclicos sustituidos, procedimiento para su preparacion y composiciones que los contienen.
EG20525A (en) Benzopyrans
CA2210022A1 (en) Paroxetine hydrochloride solvates
ATE203515T1 (de) Meta-substituierte phenylsulphonamidderivate
AU2337097A (en) Meta-substituted phenylene derivatives and their use as alphavbeta3 integrin antagonists or inhibitors
BG100951A (en) Novel erythromycin derivatives, method for their preparation and their use as drugs
SG48750A1 (en) Tricyclic carbonate compounds useful for inhabition of g-protein function for treatment of proliferative diseases
LU91761I2 (fr) Vernakalant et ses dérivés pharmaceutiquement acceptables et en particulier son sel d'hydrochlorure (BRINAVESS®)
MX9804046A (es) 6-0-metil eritromicina d y proceso para hacerla.
AU672052B2 (en) Antidepressant and antiparkinsonian compounds
FI902632A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 5-substitoitujen 5,11-dihydrodibentso/b,e//1,4/tiatsepiinijohdannaisten valmistamiseksi sekä menetelmässä käyttökelpoisia välituotteita
NZ333798A (en) Arylcycloalkane carboxylic esters, their use for the treatment of urinary incontinence or irritable bowel syndrome, and method of manufacture.
NO934760D0 (no) Arylsubstituerte heterosykliske forbindelser
AU671163B2 (en) Alkyl substituted heterocyclic compounds
TW339325B (en) Novel azepane derivatives, process for the preparation thereof and pharmaceutical composition containing the same
CA2276203A1 (en) N-(pyridinylamino)isoindolines and related compounds
GB2333294A (en) Cytokine production inhibitors
CA2155837A1 (en) Benzopyrans as potassium channel openers
DE69418715D1 (en) Erythromycinderivate
AU5334196A (en) Method for the preparation of esters of anhydroecgonine
TW349096B (en) Benzothiophene compounds, intermediates, compositions, and methods